LungLife AI
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of LungLife AI generated cash of -$5,020,000, which is more than the previous year. Cash used in financing activities reached the amount of -$296,000 last year. Net change in cash is therefore -$364,000.
Cash Flow
| 2018 | -2.14M | 1.75M | 506.94K |
|---|---|---|---|
| 2019 | -3.32M | -91.90K | 3.91M |
| 2020 | -2.87M | -5.32K | 2.28M |
| 2021 | -7.53M | -1.79M | 23.83M |
| 2022 | -5.84M | -115K | -169K |
| 2023 | -5.02M | 4.95M | -296K |
LLAI.L Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 3.08M | 9.21M | 127.62K | 726.79K | 222.40K | 105.54K |
Operating activities | ||||||
Net income | -5.41M | -7.60M | -7.44M | -4.83M | -4.17M | -3.24M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 254K | 285K | 323.75K | 282.65K | 302.44K | 327.11K |
Stock-based compensation expense | 186K | 614K | 409K | 225.63K | 48.40K | 0 |
| Deferred income tax benefit | 186K | 614K | 409K | 225.63K | 48.40K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 151K | 128K | -569K | 82.12K | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -5.02M | -5.84M | -7.53M | -2.87M | -3.32M | -2.14M |
Investing activities | ||||||
Purchases Of Investments | 0 | -73K | -5.41M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -77K | -85K | -1.84M | -5.32K | -91.91K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 1.75M |
Cash generated by investing activities | 4.95M | -115K | -1.79M | -5.32K | -91.90K | 1.75M |
Financing activities | ||||||
Common Stock Issued | 0 | 2K | 23.44M | 90.51K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -255K | -207K | -123K | -120.36K | 4.15M | 0 |
Cash used in financing activities | -296K | -169K | 23.83M | 2.28M | 3.91M | 506.94K |
Net Change In Cash | -364K | -6.12M | 14.50M | -599.16K | 504.39K | 116.85K |
Cash at end of period | 2.72M | 3.08M | 14.62M | 127.62K | 726.79K | 222.40K |
| Data source | Data source | Data source | Data source | Data source | Data source |